- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
SUS
STO
Week ended 07 Aug 2026
Weekly Investor Report
Surgical Science Sweden AB (publ) · Healthcare · Health Information Services
Latest close
37.10 SEK
7.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 16.4% above the Trend Line and sits at 15.7% of its 52-week range. The latest completed week returned 7.3%, after a 20.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
36
out of 100
Latest Close
37.10 SEK
7 Aug 2026
1W Return
7.3%
latest completed week
4W Return
20.6%
short-term follow-through
12W Return
17.5%
quarterly tape
Trend Breadth
9.6%
5 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 43.49% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.3%
Latest completed week; four-week move 20.6%.
Indicator stack
12/56
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.49%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 16.4% above the Trend Line and sits at 15.7% of its 52-week range. The latest completed week returned 7.3%, after a 20.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1912-week average 0.22
12-week confirmation
Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.19Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 20.6% over four weeks, 17.5% over 12 weeks, and -63.0% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year5
Trend breadth9.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.36Latest activity-pressure read.
Pressure change-5.5%Four-week change in activity pressure.
Leadership-34.03Latest relative-leadership reading.
RS change35.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 8 relevant articles.
0 positive · 8 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-66.1%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+26.9%Week of 20 Feb.
Worst week-9.1%Week of 24 Apr.
Latest week+7.3%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks0
Modest losses9
Sharp losses6
Recent vol7.7%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank4 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Health Information Services
4-week rank1 / 7
Group average2.9%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD71.4%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape26/100
Trend, activity pressure, participation, and risk combine to a 26/100 tape read.
Indicator analysis43/100Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.19; No reversal markers Next-Week ExpectancyNegative 43.49%Next-week expectancy is negative with a 43.49% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 8 relevant articles.
Investors Give Surgical Science Sweden AB (publ) (STO:SUS) Shares A 25% Hiding Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 37.10 SEK | 7.3% | 31.88 SEK | 114.2 SEK | 0.36 | -34.03 | 681.9K | On |
| 31 Jul 2026 | 34.58 SEK | 12.1% | 31.70 SEK | 115.4 SEK | 0.16 | -39.16 | 438.7K | On |
| 24 Jul 2026 | 30.84 SEK | 2.0% | 31.58 SEK | 116.6 SEK | 0.13 | -47.61 | 656.3K | Off |
| 17 Jul 2026 | 30.24 SEK | -1.7% | 31.62 SEK | 118.0 SEK | 0.24 | -50.41 | 272.0K | Off |
| 10 Jul 2026 | 30.76 SEK | -4.4% | 31.66 SEK | 119.3 SEK | 0.38 | -52.34 | 634.4K | Off |
| 3 Jul 2026 | 32.16 SEK | 1.9% | 31.77 SEK | 120.5 SEK | 0.49 | -53.35 | 73.2K | On |
| 26 Jun 2026 | 31.56 SEK | 2.5% | 31.82 SEK | 121.8 SEK | 0.60 | -54.96 | 74.4K | On |
| 19 Jun 2026 | 30.80 SEK | -5.6% | 31.90 SEK | 123.2 SEK | 0.83 | -58.28 | 528.8K | On |
| 12 Jun 2026 | 32.62 SEK | -3.7% | 33.33 SEK | 124.5 SEK | 1.19 | -56.65 | 29.7K | Off |
| 5 Jun 2026 | 33.88 SEK | -6.8% | 34.68 SEK | 125.9 SEK | 1.23 | -56.72 | 106.4K | Off |
| 29 May 2026 | 36.36 SEK | -4.3% | 36.22 SEK | 127.1 SEK | 1.23 | -55.55 | 626.9K | Off |
| 22 May 2026 | 38.00 SEK | 20.3% | 37.81 SEK | 128.4 SEK | 1.07 | -55.19 | 2.0M | Off |
| 15 May 2026 | 31.58 SEK | -4.6% | 39.53 SEK | 129.7 SEK | 0.77 | -62.63 | 491.1K | Off |
| 8 May 2026 | 33.10 SEK | 0.9% | 41.29 SEK | 131.1 SEK | 0.82 | -62.52 | 868.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.